Skip to main content
Journal of Clinical Oncology logoLink to Journal of Clinical Oncology
. 2019 Aug 8;37(24):2187. doi: 10.1200/JCO.19.01753

Erratum

PMCID: PMC6830835  PMID: 31415725

The October 20, 2017, article by Shore et al entitled “Intravesical rAd–IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin–Refractory or Relapsed Non–Muscle-Invasive Bladder Cancer: A Phase II Randomized Study” (J Clin Oncol: 10.1200/JCO.2017.72.3064) was published with an error.

In the section Authors’ Disclosures of Potential Conflict of Interest, Colin P.N. Dinney’s disclosures were presented as “Other Relationship: FKD Therapies Oy, University of Michigan Comprehensive Center.”

They should have been presented as “Consulting or Advisory Role: FKD Therapies Oy, Research Funding: FKD Therapies Oy, Other Relationship: University of Michigan Comprehensive Center.”

This has been corrected as of July 19, 2019. Journal of Clinical Oncology apologizes for the error.


Articles from Journal of Clinical Oncology are provided here courtesy of American Society of Clinical Oncology

RESOURCES